Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px
Document › Details

KCR S.A.. (1/13/20). "Press Release: KCR Announces New Chief Commercial Officer. Bryan Katz Joins KCR’s Growing Executive Team to Take Over as Head of Commercial Strategy and Global Partnerships". Boston, MA.

Region Region Boston, MA
  Country United States (USA)
Organisations Organisation KCR, Boston Office
  Group KCR CRO (Group)
  Organisation 2 Iqvia (NYSE: IQV)
  Group Iqvia (Group)
Products Product contract research (drugs)
  Product 2 clinical research services
Persons Person Katz, Bryan (KCR 202001– CCO based in Boston before Syneos Health + IQVIA + PriceWaterhouseCoopers + Abbott Labs)
  Person 2 Jagielski, Mike (KCR CRO 201309– CEO joined 201201 before Merck & Co)
     


KCR, the international clinical development solutions provider, announced today that Bryan Katz has joined the organization in the role of Chief Commercial Officer. Mr. Katz will oversee the expansion of KCR global commercial solutions and partnerships.

Mr. Katz brings to KCR over 20 years of expertise as a trusted advisor and senior leader within the life science and pharmaceuticals industry with experience in product strategy, deal services, clinical model innovation and commercial operations.

“I am thrilled to join KCR. The company brings a truly unique patient-centric perspective to our industry that reduces the operational risk in clinical development, and I look forward to working with such a dedicated and innovative team,” says Mr. Katz.

Prior to joining KCR, Bryan held senior roles at Syneos Health, IQVIA, PriceWaterhouseCoopers and Abbott Laboratories.

“We are honored to have Bryan joining KCR as we continue to expand our geographical reach and develop our global partnerships. We feel that Bryan’s experience and knowledge will be a significant contribution to making the next step in KCR commercial development, especially as we focus on the US market,” summarizes KCR CEO, Mike Jagielski.


About KCR:

KCR is a clinical development solutions provider for the biotechnology, pharmaceutical, and medical device industries. We support clients with full-service clinical development capabilities across three main areas: Trial Execution, Consulting and Placement. KCR operates across four main regions: North America, Western Europe, Central Europe, and Eastern Europe, with a main operational hub located in Boston, MA. Our strategic hub locations, technical capabilities and solution offerings allow for the optimized delivery of trial execution strategies to develop life-changing therapies. KCR offers access to an estimated population of 1.1 Billion people. For more information visit www.kcrcro.com.

We see the human behind every number.


###


Contact:

Molly Garrity
KCR, PR & Marketing
E-mail: molly.garrity@kcrcro.com
Mobile: +1 857 753 7853

   
Record changed: 2020-02-02

Advertisement

Picture [iito] – Putting Information into Context 650x65px

More documents for KCR CRO (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px




» top